POSSIBILITIES OF USING THE IMMUNOMODULATOR GALAVIT® IN PATIENTS WITH CHRONIC TONSILLITIS

Download full text PDF
Issue: 
8
Year: 
2016

V. Svistushkin (1), MD; G. Nikiforova (1), MD; M. Leonova (2), MD; I. Pokoziy (1) 1 -I.M. Sechenov First Moscow State Medical University 2 -N.I. Pirogov Russian National Research Medical University, Moscow

The wide prevalence and global impact of tonsillar pathology on many human organs and systems predetermine the urgency of the problem of chronic tonsillitis. Due to the exceptionally important role of the tonsils in the processes of immunogenesis, indications for tonsillectomy should be strictly defined. In the absence of absolute indications for tonsillectomy, medical treatment that preserves the immunological functions of tonsillar lymphoid tissue seems to be most appropriate. Immunotropic therapy can improve the efficiency of treatment in patients with chronic tonsillitis.
Keywords: 
otorhinolaryngology
chronic tonsillitis
immunity
medical treatment
immunotropic agents
Galavit®

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Aref'eva N.A. Tonzilljarnaja patologija. Sovremennoe sostojanie pro blemy // Vestn. otorinolaringol. – 2012; 6: 10–3.
  2. Pal'chun V.T., Luchihin L.A., Krjukov A.I. Vospalitel'nye zabolevanija glotki. Rukovodstvo dlja vrachej / M.: GEOTAR-Media, 2007; 288 s.
  3. Pluzhnikov M.S., Lavrenova G.V., Levin M.Ja. i dr. Hronicheskij tonzil lit. Klinika i immunologicheskie aspekty / SPb: Dialog, 2005; 221 s.Rukovodstvo po otorinolaringologii. Pod red. I.B. Soldatova / M.: 4. Meditsina, 1994; 608 s.
  4. Tsvetkov E.A. Naumenko N.N. Limfoepitelial'noe glotochnoe kol'tso v immunnoj sisteme organizma // Effektivnaja meditsina. – http://www.medeffect.ru/so/immun.shtm.
  5. Popov E.L., Mal'tseva G.S., Vlasova V.V. i dr.. Immunologicheskie aspek ty hronicheskogo tonzillita // Ros. otorinolaringol. – 2002; 2: 37–44.
  6. Bykova V.P. Sovremennyj aspekt tonzilljarnoj bolezni // Arh. patol. – 1996; 3: 22–30.
  7. Mejl D., Brostoff Dzh., Rot D.B. i dr. Immunologija / M., 2007; 556 s.8.
  8. Bykova V.P. Strukturnye osnovy mukozal'nogo immuniteta verhnih dyhatel'nyh putej // Ros. rinol. – 1999; 1: 5–9.
  9. Zabolotnyj D.I. Mel'nikov O.F. Teoreticheskie aspekty geneza i terapii hronicheskogo tonzillita / Kiev: Zdorov'ja, 1999; 145 s.
  10. Ponomarev L.E., Shubich M.G. Aktual'nye voprosy tonzilljarnoj immu nologii // Novosti otorinolaringol. i logopatol. – 1998; 2: 105–10.
  11. Klimov V.V., Kologrivova E.N., Cherevko N.A. i dr. Klinicheskaja immu nologija i allergologija / Tomsk, 2005; 180 s.
  12. Pal'chun V.T., Gurov A.V., Aksenova A.V. i dr. Sovremennye predstavle nija o toksiko-allergicheskih projavlenijah hronicheskoj tonzilljarnoj pato-logii, ego etiologicheskaja i patogeneticheskaja rol' v vozniknovenii i teche-nii obschih zabolevanij. // Vestn. otorinolaringol. – 2012; 2: 5–12.
  13. Pal'chun V.T. Klassifikatsija i lechebnaja taktika pri hronicheskom tonzillite // Vestn. otorinolaringol. – 2013; 3: 8–11.
  14. Latysheva T.V., Setdikova N.H., Man'ko K.S. Vtorichnye immunodefi tsity. Vozmozhnosti ispol'zovanija otechestvennogo immunomoduljatora Galavit // Tsitokiny i vospalenie. – 2005; 3: 95–9.
  15. Rumjantsev A.G., Scherbina A.Ju. Effektivnost' preparata Galavit u chasto i dlitel'no bolejuschih detej starshe 6 let // Ros. vestn. perinatol. i pediat. – 2008; 6: 76–7.
  16. Sologub T.V., Osinovets O.Ju. Immunomoduljatory v kompleksnoj tera pii ORVI: vozmozhnosti primenenija preparata Galavit // Rus. med. zhurn. – 2013; 3: 144–6.